Basilea Pharmaceutica AG (0QNA.L) LSE

55.27

+0.76544(+1.40%)

Updated at December 23 05:44PM

Currency In CHF

Valuation

Market Cap499.91M
Enterprise Value490.88M
P/E Ratio10.66
PEG Ratio-0.59
Price/Sales Ratio3.68
Price/Book Ratio6.69
Enterprise/Revenue3.5
Enterprise/EBITDA9.85

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.35
Operating Margin0.35

Management Effectiveness

Return On Assets0.26
Return On Equity0.7

Income Statement

Revenue208.54M
Revenue/Share14.73
Gross Profit169.86M
EBITDA63.13M
Net Income77.59M
Diluted EPS5.83

Balance Sheet

Total Cash128.37M
Total Cash/Share10.27
Total Debt96.79M
Total Debt/Equity0.94
Current Ratio6.32
Book Value Per Share8.25

Price History

52-Week Change32.85
52-Week High55.9
52-Week Low32.2
Moving Average 50 Days35.23
Moving Average 200 Days39.55

Statistics

Average Volume4,885
Shares Outstanding12.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A